ArticleMedicine2026
The association between obesity indices and hypertension in adults with different glycemic status: A population-based cross-sectional study of the Bandare-Kong cohort.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Obesity and hypertension (HTN) frequently coexist with dysglycemia, yet it remains unclear whether general (BMI) versus central (waist circumference, WC) obesity indices show differential associations with HTN across normoglycemic, prediabetic, and diabetic states. This population-based study aimed to assess this relationship among adults aged 35 to 70 from the Bandare-Kong cohort. HTN was determined based on systolic blood pressure ≥130 mm Hg, diastolic blood pressure ≥80 mm Hg, or self-reported use of antihypertensive medication. Obesity was defined by body mass index (BMI) ≥30 kg/m2 or WC ≥102 cm in men and WC ≥88 cm in women. Participants were stratified as normoglycemic (fasting plasma glucose [FPG] < 100 mg/dL), prediabetic (FPG 100-125 mg/dL), or diabetic (self-reported diabetes or FPG ≥126 mg/dL). Multivariable logistic regression models were used to estimate adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Of 3916 participants (mean age 48.3 years; 42.8% male), 60.1% were normoglycemic. Multivariable analysis indicated that among diabetic individuals, high WC alone (aOR = 3.19, 95% CI: 1.18-5.60, P < .01) and combined obesity (aOR = 3.09, 95% CI: 1.77-5.39, P < .01) were associated with higher odds of HTN. The high-BMI-only category among diabetic participants was not interpreted inferentially because it contained only 2 normotensive individuals, resulting in an unstable estimate. In the prediabetic group, participants with combined obesity had the highest odds of HTN (odds ratio = 2.53, 95% CI: 1.58-4.15, P < .01), followed by those with high WC alone (odds ratio = 1.99, 95% CI: 1.21-3.27, P < .01). Among normoglycemic individuals, combined obesity was associated with higher odds of HTN (aOR = 2.63, 95% CI: 2.01-3.44, P < .01), followed by high WC alone (aOR = 1.44, 95% CI: 1.10-1.86, P < .01). Central obesity, either alone or combined with general obesity, was consistently associated with higher odds of HTN across glycemic strata. These findings support the importance of WC-based obesity assessment in HTN risk evaluation. Longitudinal studies with adequately sized diabetic subgroups are needed to confirm these associations and establish temporality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.